← Amit Kumar

Medicines we misuse

Zoya deserves ice cream

Steroid phobia, and the cost of misunderstanding the script. Why India's most misunderstood medicine sits unused on the shelf.

May 2026 · 6 min read

A mother bought the inhaler. She filled the prescription. She paid for it. And then she put it on the shelf and stopped using it.

Not because of cost. Not because of access. Because of one word: steroid.

Her daughter Zoya is nine years old and has asthma. In the years before that prescription, her mother had tried everything to protect her: homeopathy, Ayurvedic preparations, dietary protocols. When those didn’t stop the attacks, she built a wall of restrictions around Zoya’s life. No air conditioning, even in a 45°C Uttar Pradesh summer. No ice cream. No chocolate. No cold water. No outside food, ever. The list grew with each neighbour’s advice and each WhatsApp forward about asthma triggers.

Think about what that means for a child. Watching friends eat cake at her own birthday party. Sweating in a closed room while her cousins sit under the fan next door. Declining every street-food stall on a school trip. At nine, she has already learned that her body is a source of danger and that joy is something to be rationed.

And despite all of it, the restrictions, the alternative medicines, the vigilance, Zoya still had attacks. Still had emergency visits. Still wheezed. Eventually a pulmonologist prescribed what she had needed all along: a low-dose inhaled corticosteroid, taken daily as a preventer.

Her mother gave it. Zoya improved, as children on inhaled steroids reliably do. And then her mother stopped it. Not once, but every time Zoya seemed “a bit normal”. She is better. Why give her a steroid if she is fine? The inflammation rebuilt itself quietly, the next cold or dust storm set it alight, and the cycle began again.

The detail that makes this story harder to tell: Zoya’s mother has asthma herself. The fear that keeps the inhaler away from her daughter may be keeping it away from her own lungs too. Steroid phobia does not distinguish between patient and caregiver. It passes from one generation to the next, sometimes through the same household’s lungs.

A fear with a medical name

Across India, this is not a rare story. It has a name, corticophobia, and it is one of the biggest single drivers of poor asthma outcomes in this country. India carries one of the heaviest asthma and COPD burdens in the world, yet inhaler adherence remains among the lowest anywhere.

The confusion in a family’s mind is understandable. In much of India, “steroid ki dawai” means the injections sold in gymnasiums, the cricketer who was banned, the relative whose sugar spiralled after a course of oral dexamethasone. It means kidney damage whispered about in the mohalla. A prescription for a child is filtered through the mother, reviewed by the father, cross-checked by the grandmother and, often, put to a vote in the family WhatsApp group. Every one of those people carries a version of the same fear.

Then there is the chemist. For a large part of India the pharmacy is the first and last point of medical contact. A mother reads “corticosteroid” on the label and asks whether it is safe. “Haan, steroid hai, dhyan se dena” is a sentence that has ended countless treatment plans.

What the science actually says

The word is shared. Nearly everything else is different.

When a patient swallows an oral steroid tablet such as prednisolone, around 80–90% of it enters the bloodstream and travels to every organ. That is the drug, at high doses or over long periods, that carries the risks people fear: bone loss, diabetes, weight gain, adrenal suppression.

An inhaled corticosteroid behaves differently. It is delivered straight to the lining of the airway, acts there, and whatever little is absorbed is rapidly inactivated by the liver. For the commonly used molecules (budesonide, fluticasone, beclomethasone) at standard doses, less than 1–2% reaches the circulation in active form. Used consistently, inhaled steroids cut emergency visits and hospital admissions dramatically.

Anabolic steroids, systemic corticosteroids and inhaled corticosteroids are three different worlds. They share a word and very little else. Until that distinction lives in the family’s mind, no reassurance will land.

Why “don’t worry” doesn’t work

When a doctor says, “It’s a low-dose steroid, don’t worry,” the patient hears steroid and stops listening. The brain processes the threat before it processes the reassurance, and an explicit “don’t worry” often makes the worry louder. The same goes for “the side effects are rare”, “everyone uses steroids these days” and “trust me, it’s fine”. Each tries to push the fear aside instead of replacing it with a better picture.

What works is different language, chosen on purpose:

  • “This is a protective medicine that works only inside the breathing tube. Think of it as a helmet for your child’s airways.”
  • “Of everything your child breathes in, less than one drop in a hundred reaches the blood. It stays in the lungs and works there.”
  • “The medicine you are afraid of, the steroid tablet, is what we use in emergencies. This inhaler is what keeps us from ever reaching that emergency.”

The helmet works as an analogy because it matches the pharmacology. A helmet does not change who you are. It protects one part of you from one kind of harm, and it works by being worn every day, before the fall, not after.

A consultation that actually moves a frightened parent tends to follow the same six steps:

  1. Acknowledge. “I understand why the word steroid worries you. Many families feel the same. Let me explain why this is different.”
  2. Reframe. Call it what it does: a protective airway medicine.
  3. Localise. Make the “less than 1%” fact concrete: one drop in a hundred.
  4. Contrast. The tablet goes everywhere and is for emergencies. The inhaler stays in the airway and prevents them.
  5. Quantify the benefit. Fewer attacks, fewer nights in hospital, fewer missed school days.
  6. Invite questions. “What worries you most? I want you to leave here confident.”

Language is a clinical intervention. What a doctor leaves behind in a consultation decides what happens after the door closes.

Two truths nobody told Zoya’s mother

Asthma never fully switches off. Even in a child who looks completely well between attacks, a low level of airway inflammation persists, like embers under ash. The inhaler does not cure asthma. It keeps those embers from catching. Stopping it because the child “seems fine” is like taking the smoke detector off the kitchen ceiling because nothing is burning right now.

With a low-dose inhaled steroid, or a low-dose ICS+LABA where needed, a child with asthma can live a completely normal life. She can eat ice cream. She can sit under the air conditioner, share the birthday cake, go on the school trip and run on sports day.

Which is the torturous option?

Set the two choices side by side. On one side: no air conditioning in a 45-degree summer, no ice cream at birthday parties, no outside food, years of remedies with no evidence behind them, and attacks that happened anyway. On the other: two puffs through a spacer, morning and evening, thirty seconds each.

In trying to protect her daughter from a harsh medicine, Zoya’s mother has given her a harsh childhood, one that is joyless, medically unnecessary and, in the end, ineffective. The inhaler was never the torturous option. Life without it is.

Zoya deserves ice cream. She deserves a cool room in an Indian summer and a childhood without a list of prohibitions that science does not support. She deserves what every child with asthma deserves: a two-puff answer to a problem that has been treated as though it required a lifetime of suffering.

To every doctor, pharmacist and respiratory professional reading this: the script has been wrong for too long. Less than 1% reaches the blood. Far fewer emergencies. This is not a steroid the way they fear it. It is a helmet for the airway.

Hum saans lenge, bina darr ke. We will breathe, without fear.

Amit Kumar is co-founder of Bayu Healthcare and has spent twenty-six years in Indian respiratory medicine. Disagree, or have a field story to share? Write to me on LinkedIn.